GLP1R and diabetes mellitus: Nevertheless, a specific GIP antagonist for human use is currently available and its use in future studies may help us understand better the role of GIP as well as the role of the combined GIP/GLP-1 action on glucose homeostasis and diabetes remission after bariatric surgery [155].